GlassScriptPhysician profile
Steven J Eskin
NPI 1386686194
$481.09
in general payments reported to CMS, 2019-2025
9 companies · $18.82 in 2025
The $18.82 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $32.18 · 2021: $57.88 · 2022: $72.94 · 2023: $60.35 · 2024: $76.58 · 2025: $18.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.75 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $167.52 | 2019-2025 | Eliquis, Camzyos |
| Csl Behring | $69.94 | 2019-2024 | Kcentra |
| Pfizer INC. | $52.61 | 2019-2024 | |
| Allergan, INC. | $42.50 | 2019 | |
| Alexion Pharmaceuticals, INC. | $41.68 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $32.47 | 2020-2023 | Andexxa |
| Bioxcel Therapeutics, INC. | $27.56 | 2023 | Igalmi |
| Melinta Therapeutics, LLC | $23.62 | 2019 | |
| Abbott Laboratories | $23.19 | 2024 | I-Stat |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Eskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.